Ana Raquel-Cunha

  • biomarker
  • EGFR
  • lung cancer
  • molecular targeted therapies
  • oncobiology
  • RKIP

Ana Raquel-Cunha has a degree in Applied Biology (2014/2017), a post-graduation in Applied Biochemistry(2017/2018) and a master’s degree in Health Sciences by University of Minho (2018/2019). She is, since September 2019, a PhD student in the doctoral program of Health Sciences in University of Minho, developing her dissertation in understanding the role of RKIP protein as a novel predictor of EGFR targeted therapies in lung cancer. She has 2 published articles, 2 book chapters, 2 oral presentations and 20 conference posters.

Scientific Highlights

Diana Cardoso-Carneiro, Ana Raquel-Cunha, Joana Pinheiro, Maria Gabriela-Freitas, Patrícia Fontão, Rui M. Reis, Olga Martinho. Chapter 20, in “Prognostic and Therapeutic Applications of RKIP in Cancer”, Benjamin Bonavida & Stavroula Baritaki. Elsivier Academic Press. 2020.
Maria Gabriela-Freitas, Joana Pinheiro, Ana Raquel-Cunha, Diana Cardoso-Carneiro, Olga Martinho. 2019.”RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer”. Biomolecules 9 (12): 769.
Ana Raquel-Cunha, Diana Cardoso-Carneiro, Rui M. Reis, Olga Martinho. 2019.”Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling”. Cells 8 (5): 442.